161 related articles for article (PubMed ID: 24244663)
1. Cyclic nucleotide dependent dephosphorylation of regulator of G-protein signaling 18 in human platelets.
Gegenbauer K; Nagy Z; Smolenski A
PLoS One; 2013; 8(11):e80251. PubMed ID: 24244663
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets.
Gegenbauer K; Elia G; Blanco-Fernandez A; Smolenski A
Blood; 2012 Apr; 119(16):3799-807. PubMed ID: 22234696
[TBL] [Abstract][Full Text] [Related]
3. Modulating platelet reactivity through control of RGS18 availability.
Ma P; Ou K; Sinnamon AJ; Jiang H; Siderovski DP; Brass LF
Blood; 2015 Dec; 126(24):2611-20. PubMed ID: 26407691
[TBL] [Abstract][Full Text] [Related]
4. Cyclic Nucleotide-dependent Protein Kinases Target ARHGAP17 and ARHGEF6 Complexes in Platelets.
Nagy Z; Wynne K; von Kriegsheim A; Gambaryan S; Smolenski A
J Biol Chem; 2015 Dec; 290(50):29974-83. PubMed ID: 26507661
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.
Huang J; Zhou H; Mahavadi S; Sriwai W; Murthy KS
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C200-8. PubMed ID: 16885398
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.
Nalli AD; Kumar DP; Al-Shboul O; Mahavadi S; Kuemmerle JF; Grider JR; Murthy KS
Cell Biochem Biophys; 2014 Nov; 70(2):867-80. PubMed ID: 24777815
[TBL] [Abstract][Full Text] [Related]
7. The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in platelets.
Comer S; Nagy Z; Bolado A; von Kriegsheim A; Gambaryan S; Walter U; Pagel O; Zahedi RP; Jurk K; Smolenski A
J Thromb Haemost; 2020 Nov; 18(11):3002-3012. PubMed ID: 32692911
[TBL] [Abstract][Full Text] [Related]
8. The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.
Kumm EJ; Pagel O; Gambaryan S; Walter U; Zahedi RP; Smolenski A; Jurk K
Cells; 2020 Feb; 9(2):. PubMed ID: 32085646
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of SHP-1 from spinophilin during platelet activation exposes an inhibitory binding site for protein phosphatase-1 (PP1).
Ma P; Foote DC; Sinnamon AJ; Brass LF
PLoS One; 2015; 10(3):e0119496. PubMed ID: 25785436
[TBL] [Abstract][Full Text] [Related]
10. A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling.
Ma P; Cierniewska A; Signarvic R; Cieslak M; Kong H; Sinnamon AJ; Neubig RR; Newman DK; Stalker TJ; Brass LF
Blood; 2012 Feb; 119(8):1935-45. PubMed ID: 22210881
[TBL] [Abstract][Full Text] [Related]
11. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization. Independent modulation of Tp alpha signaling by nitric oxide and prostacyclin.
Reid HM; Kinsella BT
J Biol Chem; 2003 Dec; 278(51):51190-202. PubMed ID: 14530262
[TBL] [Abstract][Full Text] [Related]
12. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
13. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
Eckly-Michel A; Martin V; Lugnier C
Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
[TBL] [Abstract][Full Text] [Related]
14. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
15. The contribution of serine residues 1588 and 1755 to phosphorylation of the type I inositol 1,4,5-trisphosphate receptor by PKA and PKG.
Soulsby MD; Alzayady K; Xu Q; Wojcikiewicz RJ
FEBS Lett; 2004 Jan; 557(1-3):181-4. PubMed ID: 14741364
[TBL] [Abstract][Full Text] [Related]
16. A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes.
Nagata Y; Oda M; Nakata H; Shozaki Y; Kozasa T; Todokoro K
Blood; 2001 May; 97(10):3051-60. PubMed ID: 11342430
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic nucleotide-dependent kinases in vitro and in rat cerebellar slices in situ.
Haug LS; Jensen V; Hvalby O; Walaas SI; Ostvold AC
J Biol Chem; 1999 Mar; 274(11):7467-73. PubMed ID: 10066812
[TBL] [Abstract][Full Text] [Related]
18. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
19. Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle.
Murthy KS; Zhou H
Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G221-30. PubMed ID: 12529267
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
